Zdrowie i gospodarka · 12/05/2021

FDA Releases Updated Guidance for COVID-19 Drug Development

The US Food and Drug Administration (FDA) has announced the availability of a revised final guidance for industry on developing drugs and biological products for the treatment or prevention of COVID-19, addressing the evolving landscape of the pandemic and the emergence of SARS-CoV-2 variants.